Literature DB >> 24009480

Neuropathology of the blood-brain barrier in epilepsy: support to the transport hypothesis of pharmacoresistance.

Mohamad Koubeissi.   

Abstract

Entities:  

Year:  2013        PMID： 24009480      PMCID： PMC3763601          DOI： 10.5698/1535-7597-13.4.169

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  10 in total

Review 1.  Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies?

Authors:  Heidrun Potschka
Journal:  Epilepsia       Date:  2010-04-30       Impact factor: 5.864

2.  Intrinsic severity as a determinant of antiepileptic drug refractoriness.

Authors:  Michael A Rogawski; Michael R Johnson
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

3.  Early identification of refractory epilepsy.

Authors:  P Kwan; M J Brodie
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

4.  The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy.

Authors:  Claudia Brandt; Kerstin Bethmann; Alexandra M Gastens; Wolfgang Löscher
Journal:  Neurobiol Dis       Date:  2006-08-22       Impact factor: 5.996

Review 5.  Molecular and cellular mechanisms of pharmacoresistance in epilepsy.

Authors:  Stefan Remy; Heinz Beck
Journal:  Brain       Date:  2005-11-29       Impact factor: 13.501

Review 6.  Drug resistance in brain diseases and the role of drug efflux transporters.

Authors:  Wolfgang Löscher; Heidrun Potschka
Journal:  Nat Rev Neurosci       Date:  2005-08       Impact factor: 34.870

7.  Neuropathology of the blood-brain barrier and pharmaco-resistance in human epilepsy.

Authors:  Joan Y W Liu; Maria Thom; Claudia B Catarino; Lillian Martinian; Dominique Figarella-Branger; Fabrice Bartolomei; Matthias Koepp; Sanjay M Sisodiya
Journal:  Brain       Date:  2012-06-28       Impact factor: 13.501

8.  A novel positron emission tomography imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood-brain barrier.

Authors:  Jens P Bankstahl; Marion Bankstahl; Claudia Kuntner; Johann Stanek; Thomas Wanek; Martin Meier; Xiao-Qi Ding; Markus Müller; Oliver Langer; Wolfgang Löscher
Journal:  J Neurosci       Date:  2011-06-15       Impact factor: 6.167

9.  The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

Authors:  M D Tricklebank; L Singh; R J Oles; C Preston; S D Iversen
Journal:  Eur J Pharmacol       Date:  1989-08-11       Impact factor: 4.432

10.  Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia.

Authors:  Halil Ak; Bahadir Ay; Taner Tanriverdi; Galip Zihni Sanus; Merih Is; Mehmet Sar; Buge Oz; Cigdem Ozkara; Emin Ozyurt; Mustafa Uzan
Journal:  Seizure       Date:  2007-05-07       Impact factor: 3.184
  10 in total
  2 in total

Review 1.  Drug-Resistant Epilepsy and Surgery.

Authors:  Jiyao Sheng; Shui Liu; Hanjiao Qin; Bingjin Li; Xuewen Zhang
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

2.  Comparison of intranasal versus intravenous midazolam for management of status epilepticus in dogs: A multi-center randomized parallel group clinical study.

Authors:  Marios Charalambous; Holger A Volk; Andrea Tipold; Johannes Erath; Enrice Huenerfauth; Antonella Gallucci; Gualtiero Gandini; Daisuke Hasegawa; Theresa Pancotto; John H Rossmeisl; Simon Platt; Luisa De Risio; Joan R Coates; Mihai Musteata; Federica Tirrito; Francesca Cozzi; Laura Porcarelli; Daniele Corlazzoli; Rodolfo Cappello; An Vanhaesebrouck; Bart J G Broeckx; Luc Van Ham; Sofie F M Bhatti
Journal:  J Vet Intern Med       Date:  2019-10-03       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.